Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.

Abstract

Tumor-reactive T cells exist in some CLL patients (mainly during earlier stages of disease) and may potentially mediate therapeutic responses if their numbers and activation states can be sufficiently increased by tumor vaccines.